For instance, it has been shown that intratumoral administration of LPS can induce resistance to CTLs and drives NK cell anergy [69], whereas triggering of TLR3 on certain tumor cell types results in tumor growth arrest [70]. The gene discussed is TLR3; the disease is neoplasm.